Research ArticleBEHAVIORAL PHARMACOLOGY
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J. Rahn, Alexander M. Zvonok, Ganesh A. Thakur, Atmaram D. Khanolkar, Alexandros Makriyannis and Andrea G. Hohmann
Journal of Pharmacology and Experimental Therapeutics November 2008, 327 (2) 584-591; DOI: https://doi.org/10.1124/jpet.108.141994
Elizabeth J. Rahn
Alexander M. Zvonok
Ganesh A. Thakur
Atmaram D. Khanolkar
Alexandros Makriyannis
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleBEHAVIORAL PHARMACOLOGY
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J. Rahn, Alexander M. Zvonok, Ganesh A. Thakur, Atmaram D. Khanolkar, Alexandros Makriyannis and Andrea G. Hohmann
Journal of Pharmacology and Experimental Therapeutics November 1, 2008, 327 (2) 584-591; DOI: https://doi.org/10.1124/jpet.108.141994
Research ArticleBEHAVIORAL PHARMACOLOGY
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J. Rahn, Alexander M. Zvonok, Ganesh A. Thakur, Atmaram D. Khanolkar, Alexandros Makriyannis and Andrea G. Hohmann
Journal of Pharmacology and Experimental Therapeutics November 1, 2008, 327 (2) 584-591; DOI: https://doi.org/10.1124/jpet.108.141994
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement